Details
| Stereochemistry | MIXED |
| Molecular Formula | C26H56N10.2ClH |
| Molecular Weight | 581.712 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.Cl.CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC
InChI
InChIKey=BRJJFBHTDVWTCJ-UHFFFAOYSA-N
InChI=1S/C26H56N10.2ClH/c1-5-9-15-21(7-3)19-33-25(29)35-23(27)31-17-13-11-12-14-18-32-24(28)36-26(30)34-20-22(8-4)16-10-6-2;;/h21-22H,5-20H2,1-4H3,(H5,27,29,31,33,35)(H5,28,30,32,34,36);2*1H
Alexidine dihydrochloride, an antibacterial compound, which is used during endodontic procedures. It is a dibiguanide ahent and is effective inhibitor of protein tyrosine phosphatases localized to mitochondrion 1 (PTPMT1). It was noted that PTPMT1 could serve as a pharmacological target in the treatment of type II diabetes. Alexidine dihydrochloride is also an apoptosis-promoting agent possessing the anticancer properties.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
I2A7616PY1
Created by
admin on Fri Dec 15 17:12:51 GMT 2023 , Edited by admin on Fri Dec 15 17:12:51 GMT 2023
|
PRIMARY | |||
|
102678
Created by
admin on Fri Dec 15 17:12:51 GMT 2023 , Edited by admin on Fri Dec 15 17:12:51 GMT 2023
|
PRIMARY | |||
|
DTXSID5045881
Created by
admin on Fri Dec 15 17:12:51 GMT 2023 , Edited by admin on Fri Dec 15 17:12:51 GMT 2023
|
PRIMARY | |||
|
1715-30-6
Created by
admin on Fri Dec 15 17:12:51 GMT 2023 , Edited by admin on Fri Dec 15 17:12:51 GMT 2023
|
PRIMARY | |||
|
216-994-6
Created by
admin on Fri Dec 15 17:12:51 GMT 2023 , Edited by admin on Fri Dec 15 17:12:51 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
